Doug Samuelson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Doug Samuelson
Doug Samuelson is recorded as CFO at Kairos Pharma, LTD. (KAPA). Doug Samuelson was last confirmed as CFO at GENELUX Corp (GNLX) in a filing dated July 20, 2023. GENELUX Corp reported in an 8-K filed November 24, 2023 that Doug Samuelson resigned as VP, Finance, effective November 21, 2023.
“On November 21, 2023, Doug Samuelson resigned as VP, Finance of Genelux Corporation effective as of November 21, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2023-07-20
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kairos Pharma, LTD.
Other people whose current roles at this company are on record from its filings.
- John S. Yu CEO
- Dr. Rahul Singhvi Board Member
- Hansoo Michael Keyoung Board Member
- Hyun W. Bae Board Member
- Rahul Sighvi Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.